Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
3 minute read

BrainStorm Issues 2023 Letter To Shareholders; Says Our Focus Remains To Align With The FDA On A Phase 3b Trial Design, As We Acknowledge That This Represents The Most Expedient Pathway To Approval

By Benzinga Newsdesk
December 20, 10:02 AM
BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today issued a Letter to shareholders.Dear Shareholders,We remain steadfast in our

BCLI

Read More
2 minute read

BK Technologies Board of Directors Elected Joshua S. Horowitz As Chairman of the Board; Succeeds Previous Chairman, Kyle D. Cerminara, Who Has Stepped Away From The BK Technologies Board To Focus On Other Endeavors

By Benzinga Newsdesk
December 20, 9:34 AM
BK Technologies Corporation (NYSE:BKTI) (the "Company," "BK Technologies") today announced that the Board of Directors has elected Joshua S. Horowitz as Chairman. Mr. Horowitz was elected to the Board of Directors by the

BKTI

Read More
2 minute read

Leslie’s Announces Changes To Its Board Of Directors; John Strain Assumes Role Of Lead Independent Director And Named Chairman-Elect; Steven L. Ortega Will Retire At Leslie’s 2024 Annual Meeting Of Shareholders

By Benzinga Newsdesk
December 19, 5:15 PM
Steven L. Ortega Will Retire at Leslie's 2024 Annual Meeting of Shareholders John Strain Assumes Role of Lead Independent Director and Named Chairman-ElectJames Ray, Jr., Lead Independent Director, Steps Down from

LESL